Lead Poisoning (Plumbism)

Meet the patient

A four-year-old boy is referred for developmental regression, aggression, and dropping school performance. He lives in a peeling pre-1970s flat, eats paint flakes, and has cramping abdominal pain with constipation. His blood film shows a microcytic anaemia studded with coarse blue granules.[1][5]

Across town, a 48-year-old battery-recycling worker presents with severe cramping abdominal pain, no peritonism, and a wrist that he cannot extend. Two patients, one metal, and one demand on you: take the exposure history, find the basophilic stippling, and send a whole venous blood lead. Everything below exists to do exactly that, and to know that in a child the cognitive damage you find is permanent.[1][6]

No safe level — the two non-negotiable concepts

Lead is a poison with no safe blood level, and it does not give back the IQ it has taken. These two facts shape everything else, including the public-health reflex that prevention is the only effective strategy for the cognitive damage.[1]

First, neurodevelopmental harm — IQ loss and behavioural change — occurs in children at levels once thought acceptable, so the CDC reference value is a public-health action level, not a toxicity threshold. Second, chelation lowers blood lead and rescues encephalopathy, but the TLC Trial showed succimer does not improve long-term IQ. The brain injury is permanent; treatment is about source removal, acute rescue, and stopping further exposure.[1][4]

Etymology for viva gold: plumbism is from the Latin plumbum, lead — the source of the chemical symbol Pb. Saturnism comes from Saturn, the alchemical planet assigned to lead, the heaviest of the classical metals; the slow, heavy temperament of "saturnine" gave its name to lead-induced gout and mood.[6]

Where the lead comes from — PLUMBER

The history is the investigation, and the sources cluster into one mnemonic. Name the source and you have named the exposure — and in a child, the exposure history is the single most decisive step.[1]

[1]

Children absorb about half of ingested lead against a tenth in adults, and deficiency of iron, calcium or zinc increases absorption further — which is why a malnourished child in old housing is the classic patient. There is no safe level.[1]

Three axes that set the picture

Classify lead poisoning on chronicity, host, and severity — the last one drives the chelation decision. The first two set who is in front of you; the third sets the syringe.[1]

By chronicity, acute high-dose poisoning presents with lead colic, encephalopathy, seizures and haemolytic anaemia at blood lead often over 70 micrograms/dL, while chronic low-dose exposure — the commonest modern pattern — is insidious, with subtle IQ loss in children, anaemia, hypertension and nephropathy. By host, the paediatric phenotype is neurodevelopmental, the adult occupational phenotype is gastrointestinal and peripheral-nerve dominant, and pregnancy adds transplacental fetal neurotoxicity and miscarriage.[1][2]

By severity, the blood lead level drives management: under 3.5 is the CDC childhood reference value for public-health action; 5 to 44 needs source removal, surveillance and nutrition with no chelation; 45 to 69 in children (or 50 to 70 in adults) needs oral succimer; and over 70 or any encephalopathy needs IV EDTA with dimercaprol.[1][2]

How common, and where the outbreaks live

Lead exposure is a global environmental disease that kills hundreds of thousands and steals over 20 million disability-adjusted life-years a year, with the burden concentrated in low- and middle-income countries. Paint, leaded-petrol-legacy soil, informal battery recycling, artisanal mining, traditional medicines and cosmetics carry the load.[1]

The landmark outbreaks are viva gold. In Flint, Michigan from 2014 a corrosive change of water source leached lead from old pipes and raised blood lead across the child population. In Zamfara, Nigeria in 2010, artisanal gold mining with lead-contaminated ore processed at home killed over 400 children from acute encephalopathy and drove a mass oral succimer chelation programme. The global phase-out of leaded petrol, completed only in 2021 with Algeria last, halved population blood lead over 30 years and ranks among the most cost-effective public-health measures ever.[1][3]

Why lead behaves like calcium — and how it kills the haem pathway

The central toxicological principle is that lead mimics calcium — it stores in bone, crosses the blood-brain barrier and placenta, and deposits in developing teeth and bone. Everything else follows from that mimicry and from two blocked enzymes.[6][1]

Absorption and distribution. Lead is absorbed gastrointestinal (the principal route in children, about 50 per cent against 10 per cent in adults, enhanced by iron, calcium and zinc deficiency), respiratory (near-complete for inhaled dust and fumes, the occupational route), and skin (negligible for inorganic lead, but organic tetraethyl lead — the former petrol additive — is well absorbed and causes a predominantly CNS "loony gas" encephalopathy). In blood, over 99 per cent is bound to erythrocytes with a half-life of about 30 days, so blood lead reflects recent exposure; soft tissues turn over in weeks; and bone holds over 90 per cent of the adult body burden with a half-life of years to decades. Bone lead is mobilised in pregnancy, lactation, menopause and osteoporosis — so childhood exposure can re-poison a woman and her fetus decades later.[1]

The haem block — basophilic stippling

Lead poisons haem synthesis at two enzyme steps, and the blood film is the signature. It inhibits ALA dehydratase, blocking the condensation of two ALA molecules to porphobilinogen so urinary ALA rises, and ferrochelatase, blocking the insertion of iron into protoporphyrin so zinc inserts instead and zinc protoporphyrin accumulates in red cells. The result is impaired haemoglobin synthesis — a sideroblastic, microcytic, hypochromic anaemia with ringed sideroblasts in the marrow — and on the blood film the pathognomonic basophilic stippling, coarse blue-purple granules of aggregated degenerated ribosomes that the lead-damaged red cell cannot clear. Note: lead inhibits ALA dehydratase and ferrochelatase, not ALA synthase — that distinction is the porphyria trap.[1][6]

The systems lead injures

The developing brain bears the irreversible injury. Lead disrupts synaptogenesis, neurotransmitter release, NMDA receptor function, second-messenger signalling and myelination, and induces neuronal apoptosis — producing irreversible IQ loss, behavioural change, and at high levels acute lead encephalopathy with cerebral oedema, seizures and coma. The dose-response has no threshold.[1]

The peripheral nervous system gets a predominantly motor axonal neuropathy with segmental demyelination that prefers long motor nerves — classically the radial nerve (wrist drop) and the common peroneal nerve (foot drop) — with sensation relatively spared. The kidney gets proximal tubular damage: Fanconi syndrome in children with high acute exposure, and chronic tubulointerstitial nephritis with progressive impairment and hypertension in chronic exposure. The gut gets lead colic — spasm of intestinal smooth muscle and severe cramping abdominal pain with constipation. Chronic exposure also inhibits renal uric acid excretion to cause saturnine gout, raises blood pressure through renal tubular damage and altered nitric-oxide signalling, and reduces fertility in both sexes while causing miscarriage, prematurity and low birth weight.[1][2]

The clinical face — read the age

The face of lead poisoning depends on the age of the patient and the level and chronicity of exposure. In children the brain dominates; in adults the gut and the peripheral nerve.[5][1]

In children, chronic low-level exposure shows as developmental delay, speech delay, learning disability and behavioural change — attention deficit, hyperactivity, aggression — often the only clues and easily mistaken for a primary behavioural disorder. Higher levels add lethargy, irritability, anorexia, vomiting and constipation, and the life-threatening acute lead encephalopathy of ataxia, drowsiness, seizures and coma with raised intracranial pressure, typically at blood lead over 70 micrograms/dL.[1]

In adults the classical picture is lead colic — intermittent, severe, cramping abdominal pain with constipation, localised and without peritonism or fever, easily confused with an acute surgical abdomen — and a motor peripheral neuropathy that develops insidiously: wrist drop is the hallmark, foot drop less common, sensation usually spared. Constitutional fatigue, headache, irritability and memory impairment are common, and anaemia brings pallor and exertional dyspnoea.[1]

Three named signs to actively look for: the Burton line — a blue-grey gum line of precipitated lead sulfide at the gingival margin, more prominent with poor dental hygiene and absent in the edentulous; the metaphyseal lead lines on long-bone X-ray in children — dense transverse bands at the distal femur, proximal tibia and distal radius where lead deposits in the growing metaphysis; and the wrist drop of radial-nerve palsy. In atypical presentations, hypertension or chronic kidney disease may be the sole manifestation in the elderly, osteoporosis may mobilise bone lead, a retained bullet may leach for years if intra-articular, and pregnancy may unmask old bone stores as miscarriage or pre-eclampsia.[1][6]

The mimics — and the porphyria trap

Lead mimics commoner conditions, and the differentiator is always the exposure history plus the blood lead. The most examined mimic is acute intermittent porphyria, which blocks the same haem pathway.[2][5]

[1]

The single most examined differential is lead versus acute intermittent porphyria. Both block the haem or porphyrin pathway and produce the triad of abdominal pain, peripheral neuropathy and neurological or psychiatric symptoms. Porphyria adds photosensitivity, red wine-coloured urine on standing, a positive family history, and raised urinary porphobilinogen; lead adds basophilic stippling, a gum line, an exposure history, and raised urinary ALA with normal porphobilinogen. The enzyme blocks differ too — porphobilinogen deaminase in porphyria, ALA dehydratase and ferrochelatase in lead.[1]

The history is the investigation

Take a structured exposure history before you order a single test. Walk through housing (age, paint condition, renovation, lead plumbing), occupation (battery work, smelting, demolition, ammunition, soldering, radiator repair, pottery), hobbies (stained glass, jewellery soldering, fishing-weight casting, reloading), traditional remedies and cosmetics (surma, kohl, sindoor, Bhasmas), behaviour (pica, hand-to-mouth), and household members — including take-home exposure on a worker's clothes.[1]

The focused examination looks for the named signs: blood pressure for lead-related hypertension, the mouth for a Burton line, the abdomen for diffuse tenderness without peritonism, the nervous system for motor weakness with spared sensation and developmental assessment in children. Send an abdominal X-ray for radiopaque flecks of ingested lead or pica material to guide whole-bowel irrigation, and in children a long-bone X-ray for dense transverse metaphyseal lead lines — a high-burden sign.[1][2]

Investigations — the whole venous blood lead

The definitive test is the whole venous blood lead level. Use venous blood — capillary finger-prick samples are prone to skin contamination and are only for screening, so a high capillary result must be confirmed venously. Blood lead reflects recent exposure because of the roughly 30-day blood half-life.[1][2]

The first-line panel is the whole venous blood lead, a full blood count showing microcytic hypochromic anaemia, a peripheral film with basophilic stippling, iron studies to separate sideroblastic block from iron deficiency (ferritin and marrow iron are normal or high in lead), and a marrow with ringed sideroblasts on Prussian-blue staining. The supporting tests for chronic exposure are zinc protoporphyrin, which is elevated and integrates over the 120-day red-cell lifespan so it marks chronic burden better than blood lead, urinary ALA which is elevated, renal function and urinalysis for tubulointerstitial nephritis or Fanconi syndrome, serum uric acid for saturnine gout, a pregnancy test, and Hb electrophoresis if thalassaemia is in the differential.[1]

[1] [2]

[1]

Acute lead encephalopathy — the time-critical emergency

The encephalopathic child is a medical emergency, and the first chelator given must be dimercaprol. Begin with ABCDE — secure the airway because encephalopathic patients lose airway reflexes, give high-flow oxygen, establish IV access, and monitor continuously. Treat seizures with IV lorazepam (adult 4 mg, child 0.1 mg/kg) or diazepam, then phenytoin or levetiracetam if recurrent, and manage raised intracranial pressure with head-of-bed elevation to 30 degrees, normocapnia, and hypertonic saline or mannitol, avoiding over-hydration.[2][5]

The critical reflex is the chelation sequence. Give dimercaprol first, 75 mg per square metre deep intramuscularly every four hours for five days — it crosses the blood-brain barrier and chelates brain and soft-tissue lead, preventing the rise in brain lead that EDTA would otherwise cause. Start calcium disodium EDTA four hours after the first dimercaprol dose, 1500 mg per square metre per day by continuous IV infusion over five days — and always as the calcium disodium salt, never the disodium salt alone, which chelates serum calcium and causes fatal hypocalcaemia. Add oral succimer once the enteral route is tolerated. Decontaminate by removing the patient from the source, washing skin and hair, and whole-bowel irrigation with polyethylene glycol if radiopaque material is seen on abdominal X-ray.[1][4]

The two pillars — source removal and chelation

Definitive management stands on two pillars, and the first is non-negotiable in every case: identify and eliminate the source. Without source removal, chelation is futile because re-exposure is certain. Remediate lead paint with certified contractors using wet methods and HEPA vacuuming — never dry-sand or scrape, which generates dust — replace lead plumbing, change occupation or institute workplace controls, stop cosmetics and remedies, and surgically excise an intra-articular retained lead fragment if symptomatic with elevated levels. Correct iron, calcium and zinc deficiency to reduce absorption, and notify public health for environmental investigation and case-finding in the household.[1][2]

The three chelators

The second pillar is chelation, chosen by severity, and the three agents each have a route and a trap. Know them by agent, dose, route and timing.[2][3]

[1] [1]

The exam-defining rule is the sequence in encephalopathy: dimercaprol first, EDTA four hours later, succimer orally once tolerated. The rationale is that EDTA alone mobilises lead from bone and transiently raises brain lead, worsening encephalopathy; dimercaprol chelates the brain and tissue lead first, after which EDTA safely clears the blood lead.[2]

Monitor blood lead through chelation — expect a fall, then a rebound as lead redistributes from bone, so repeat courses may be needed — alongside renal function for EDTA nephrotoxicity, LFTs and FBC for succimer effects, and serum zinc, iron and copper because all chelators deplete essential metals. Treat hypertension, constipation and gout supportively, correct coexisting iron deficiency only after the lead is addressed (iron deficiency increases absorption), and repeat blood lead every 1 to 3 months until two consecutive levels are below the action range.[1]

Subtypes and scenarios that change the plan

The paediatric, occupational, encephalopathic, pregnant and retained-bullet subtypes each rewrite the algorithm. Name the subtype and the threshold and the chelator pivot.[4]

The paediatric subtype is the most important — children under 6 absorb about half of ingested lead and have a developing brain with no safe level. Screen high-risk children (older housing, low income, recent immigrants, siblings of cases) at 9 to 12 months and again at 24 months, confirm capillary results venously, use weight-based chelation, and provide developmental and early-intervention services. The TLC Trial confirmed that succimer lowers blood lead without improving long-term IQ, so prevention is the only effective strategy.[1][4]

The occupational subtype is driven by inhalation of lead dust and fumes in battery work, smelting, foundry, demolition, ammunition, soldering, radiator repair and pottery; take-home exposure on work clothes and hair is a major source of childhood lead in workers' families. Workplace surveillance uses blood lead and zinc protoporphyrin, engineering controls, respirators, on-site laundering, and medical removal from exposure when blood lead exceeds workplace limits. The encephalopathy subtype carries 25 to 40 per cent mortality even with chelation, with permanent deficits in survivors — BAL first, EDTA four hours later, ICU support.[2][5]

In pregnancy, lead crosses the placenta to cause fetal neurotoxicity, miscarriage, prematurity and low birth weight, and is mobilised from maternal bone — reduce exposure, supplement calcium and iron, and chelate only if severe, weighing the limited succimer data. In lactation, lead passes into breast milk; if maternal blood lead is high, use formula. A retained bullet or fragment leaches lead over years, especially if intra-articular or in a synovial bursa — chelate only if symptomatic with elevated blood lead, and surgically remove an intra-articular fragment as definitive treatment. The surma, kohl and sindoor exposure is culturally specific and common in South Asian and Middle Eastern families — screen children from these communities and counsel lead-free products.[1]

The preventable harm — pitfalls that recur

The recurring failures in lead poisoning trace to a short list, and most are preventable. The single commonest management failure is re-exposure because the source was not remediated — never discharge a child into an unremediated home. Confusing lead colic with an acute surgical abdomen leads to unnecessary laparotomy; lead colic has no peritonism. Confusing lead with iron deficiency or thalassaemia — check the blood lead and zinc protoporphyrin — matters because iron deficiency increases absorption, so do not give iron alone in suspected lead poisoning before confirming the diagnosis.[1]

The chelation pitfalls kill: using EDTA alone in encephalopathy worsens brain lead, so always give dimercaprol first; using the disodium EDTA salt instead of the calcium disodium salt causes fatal hypocalcaemia; and giving dimercaprol in G6PD deficiency or peanut allergy causes haemolysis or anaphylaxis. Finally, missing take-home exposure in a worker's children and treating the level but not the patient — chelation does not reverse established cognitive damage, so counselling and developmental support matter — close the list.[2][4]

Prognosis and disposition

In children the neurodevelopmental effects are permanent, persisting for life even when chelation lowers blood lead, so prevention is the only effective public-health strategy. In adults, hypertension, chronic kidney disease, gout and reproductive effects often persist despite a falling blood lead, so long-term cardiovascular and renal surveillance is warranted. Lead encephalopathy carries 25 to 40 per cent mortality even with chelation, with permanent cognitive, behavioural and motor deficits in survivors.[1][4]

Disposition follows severity. Encephalopathy or a level over 70 needs ICU with immediate dimercaprol and EDTA. Moderate poisoning needing chelation is inpatient for the course, with monitoring of blood lead, renal function and LFTs. Mild asymptomatic poisoning is outpatient with source removal, nutritional support, and repeat blood lead every 1 to 3 months until levels fall, with public-health follow-up. Confirm source remediation before discharge, provide developmental and educational support for children, and involve occupational medicine for workers.[1][2]

Evidence, guidelines, and regional practice

The anchoring references shape modern lead practice. The CDC blood lead reference value (2021) of 3.5 micrograms/dL is the 97.5th percentile of NHANES childhood levels — a public-health action level, not a clinical toxicity threshold, and there is no safe blood lead level. The TLC Trial showed succimer lowers blood lead without improving long-term IQ in children with levels of 20 to 44, confirming that chelation does not reverse established cognitive damage. The Zamfara outbreak demonstrated that mass oral succimer chelation is safe and effective in severe paediatric lead poisoning in resource-limited settings, and that chelation must be paired with environmental remediation.[1][3][4]

The Kosnett 2007 consensus provides the adult framework for occupational surveillance, medical removal, and chelation thresholds — generally reserved for symptomatic poisoning or blood lead over 50 to 70. The global leaded-petrol phase-out, completed in 2021, halved population blood lead over 30 years. Regionally, India carries high residual exposure from surma, kohl, sindoor, Ayurvedic Bhasmas, lead paint still in wide use, informal battery recycling and lead in spices — screen children from high-risk communities and counsel on cosmetics and remedies. In the United States the CDC reference value drives mandatory reporting and environmental investigation; in low- and middle-income countries informal battery recycling, artisanal mining, lead-glaze pottery and lead paint remain major sources, with population blood lead often far above high-income levels.[1][2]

[1] [2]

Ward-round test — four stems

Stem 1 — the child with developmental regression and abdominal pain (answer)

A four-year-old in peeling pre-1970s housing has developmental regression, aggression, cramping abdominal pain and constipation, and a microcytic anaemia with coarse blue granules on the blood film. What is the diagnosis, the confirmatory test, and the first management step? Model: This is lead poisoning — the basophilic stippling with microcytic anaemia, abdominal pain and developmental regression in a child with pica and old lead paint exposure. Confirm with a whole venous blood lead level (a capillary sample can be falsely high from skin contamination and must be confirmed venously), and add zinc protoporphyrin, iron studies, renal function and an abdominal X-ray for radiopaque flakes. Remove the child from the source, correct iron, calcium and zinc deficiency, and notify public health for environmental investigation. Chelate with oral succimer if the level is over 45 micrograms/dL, and remember that established IQ loss is irreversible — prevention and source removal are paramount.[1][4]

Stem 2 — the battery worker with wrist drop and colic (answer)

A 48-year-old battery-recycling worker presents with severe cramping abdominal pain, no peritonism, constipation, and a wrist he cannot extend. What is the syndrome, the trap, and the chelation? Model: This is the adult occupational triad — lead colic, motor peripheral neuropathy (wrist drop, radial nerve, sensation spared) and sideroblastic anaemia. The trap is sending lead colic to theatre as an acute abdomen; lead colic has diffuse tenderness without peritonism or fever. Confirm with a whole venous blood lead and a film for basophilic stippling, take an occupational history and screen the household for take-home exposure. Chelate with oral succimer for moderate levels over 50 to 70, or IV calcium disodium EDTA for severe over 70; remove the worker from exposure, institute engineering controls and PPE, and arrange occupational-medicine follow-up.[2][6]

Stem 3 — encephalopathy at a blood lead of 90 micrograms/dL (answer)

A three-year-old presents with ataxia, seizures and obtundation; the blood lead is 90 micrograms/dL. What is the chelation sequence, and what two contraindications must you exclude first? Model: This is acute lead encephalopathy — a medical emergency. Resuscitate (airway, seizures with lorazepam, raised ICP with head-up positioning and hypertonic saline), then give dimercaprol (BAL) first, 75 mg per square metre deep IM every four hours, and start calcium disodium EDTA four hours later at 1500 mg per square metre per day by continuous IV infusion — never EDTA alone, which raises brain lead, and always the calcium disodium salt, never the disodium salt. Before giving dimercaprol exclude G6PD deficiency (haemolysis) and peanut allergy (it is formulated in peanut oil). Add oral succimer once tolerated, admit to ICU, and expect a 25 to 40 per cent mortality with permanent deficits in survivors.[2][5]

Stem 4 — the patient with abdominal pain, neuropathy and dark urine (answer)

A 28-year-old presents with cramping abdominal pain, a motor neuropathy, and urine that darkens on standing. Is this lead or acute intermittent porphyria, and how do you separate them? Model: Both block the haem pathway and cause the triad of abdominal pain, neuropathy and neurological symptoms, so the discriminator is the laboratory and the history. Acute intermittent porphyria adds photosensitivity, red wine-coloured urine on standing, a positive family history, and raised urinary porphobilinogen with the porphobilinogen deaminase defect. Lead adds basophilic stippling, a gum lead line, an exposure history (occupation, pica, cosmetics or remedies), and raised urinary ALA with normal porphobilinogen, from ALA dehydratase and ferrochelatase inhibition. Send a whole venous blood lead, zinc protoporphyrin and urinary porphobilinogen to settle it, and remember the enzyme blocks differ.[1][6]

References

1. [1]Mayans L. Lead Poisoning in Children Am Fam Physician, 2019.PMID 31259498
2. [2]Kosnett MJ, Wedeen RP, Rothenberg SJ, et al. Recommendations for medical management of adult lead exposure Environ Health Perspect, 2007.PMID 17431500
3. [3]Thurtle N, Greig J, Cooney L, Amitai Y, et al. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data PLoS Med, 2014.PMID 25291378
4. [4]Kosnett MJ. Chelation for heavy metals (arsenic, lead, and mercury): protective or perilous? Clin Pharmacol Ther, 2010.PMID 20664538
5. [5]Miracle VA. Lead Poisoning in Children and Adults Dimens Crit Care Nurs, 2017.PMID 27902665
6. [6]Landrigan PJ, Todd AC. Lead poisoning West J Med, 1994.PMID 7941534